These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29202398)

  • 1. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
    Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
    Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
    Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
    Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy.
    Yue K; Hou X; Jia G; Zhang L; Zhang J; Tan L; Wang X; Zhang Z; Li P; Xu W; Li X; Jiang Y
    Bioorg Chem; 2021 Nov; 116():105343. PubMed ID: 34544027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.
    Jiang Y; Hou J; Li X; Huang Y; Wang X; Wu J; Zhang J; Xu W; Zhang Y
    Bioorg Med Chem; 2016 Nov; 24(22):5787-5795. PubMed ID: 27670098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
    Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
    Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
    Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
    J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
    Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
    Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
    Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles.
    Le VM; Wang JJ; Yuan M; Nguyen TL; Yin GF; Zheng YH; Shi WB; Lang MD; Xu LM; Liu JW
    Eur J Med Chem; 2015 Mar; 92():882-9. PubMed ID: 25676729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
    Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
    BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage.
    Dou C; Fang C; Zhao Y; Fu X; Zhang Y; Zhu D; Wu H; Liu H; Zhang J; Xu W; Liu Z; Wang H; Li D; Wang X
    Int J Oncol; 2017 Dec; 51(6):1775-1784. PubMed ID: 29039459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
    Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
    Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
    Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
    Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse.
    Li J; Wang X; Hou J; Huang Y; Zhang Y; Xu W
    Drug Discov Ther; 2015 Feb; 9(1):45-52. PubMed ID: 25788051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
    Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ
    Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
    Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S
    Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
    Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
    Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
    Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
    Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
    Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
    Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.